Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic Strategies

BACKGROUND: Immune reconstitution following HSCT is a complex process that strongly determines post-transplant outcomes. Delayed or impaired immune recovery increases susceptibility to opportunistic infections, viral reactivation, graft-versus-host disease, relapse, and transplant-related morbidity and mortality. OBJECTIVE: This review summarizes current evidence on the kinetics, functional recovery, and clinical significance of innate and adaptive immune reconstitution after HSCT. METHODS: A narrative review of recent literature was performed focusing on immune cell reconstitution dynamics and influencing clinical and biological factors. RESULTS: Innate immunity (neutrophils, NK cells) recovers early, providing initial defense. Adaptive immunity is delayed, driven by thymic output and peripheral T- and B-cell expansion. Regulatory T cells and γδ T cells support tolerance and graft-versus-leukemia effects. Recovery is influenced by age, conditioning, graft source, GVHD, infections, and microbiome. Numerical recovery may not equal functional immune competence. CONCLUSION: Advances in immune profiling, biomarkers, and systems immunology, along with adoptive cellular therapy and microbiome-based interventions, may enable personalized strategies to improve immune reconstitution and long-term outcomes.